MHTX — Manhattan Scientifics Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapSucker Stock
- $4.47m
- $5.38m
- $0.05m
Annual income statement for Manhattan Scientifics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.142 | 0 | 0.097 | 0.05 | 0.05 |
| Cost of Revenue | |||||
| Gross Profit | -0.047 | -0.007 | 0.097 | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | -5.52 | 4.18 | 1.12 | 0.725 | 0.737 |
| Operating Profit | 5.66 | -4.18 | -1.02 | -0.675 | -0.687 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1.55 | -8.33 | -1.22 | 4.31 | -3.64 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.55 | -8.33 | -1.22 | 4.31 | -3.64 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.55 | -8.33 | -1.22 | 4.31 | -3.64 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.55 | -8.33 | -1.22 | 4.31 | -3.64 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.012 | -0.01 | -0.002 | 0.007 | -0.007 |